Pediatrician Sanda Cohen talks about being diagnosed with Stage 4 Lung Cancer though she had never smoked. She also discusses how her treatment combination of chemotherapy and immunotherapy shrunk the main mass by nearly half in just 3 months.
Rich Daly, Chief Operating Officer at Beyond Spring Inc., a biopharmaceutical company, discusses Plinabulin, the company’s lead asset currently in late-stage development for the treatment of non-small cell lung cancer and the prevention of neutropenia, a common and often severe side effect of chemotherapy that can cause patients to delay, downgrade, decrease or even discontinue their dose.
Dr. Jan Wehkamp, M.D. Vice President and Gastroenterology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC, talks about data from the Phase 3b, STARDUST study, showing that two doses of STELARA® (ustekinumab) induced clinical remission in two-thirds of patients with Crohn’s Disease (CD). STARDUST is the first study to compare a treat to target approach with standard of care in CD and using endoscopy to guide use of medication.
Dr. Stuart Hershman, Orthopaedic Spine Surgeon at Massachusetts General Hospital, discusses his presentation from the American Academy of Orthopaedic Surgeons’ (AAOS) 2020 meeting titled “Is it the Back or Hip? Differentiating Lumbar Spine from Hip Pathologies: Key Points of Evaluation and Treatment”
Rachael Buck, Ph.D., Research Fellow at Abbott discusses necrotizing enterocolitis (NEC) in premature babies and the pre-clinical study from Johns Hopkins and Abbott, that was published in “Pediatric Research” that showed for the first time that certain human milk oligosaccharides (HMOs) can prevent the development of NEC.
Dr. William Kassler, Deputy Health Officer, and Lead Population Health Officer, at IBM Watson Health, discusses his recently published perspective “Protecting Mental Health During a Pandemic”. He also authored another report for the IBM Institute for Business Value “ How Technology and Data Can Improve Access to Mental Health Resources”.
Syneos Health Medical Director and critical care pulmonologist Dr. Keith Robinson discusses the Ventilator Initiative that is to raise awareness among healthcare providers of a bridging option, using intubated Bi-level Positive Airway Pressure (BiPAP) devices for appropriate COVID-19 patients. This is to address the predicted ventilator shortage. The open-access platform www.COVID-BiPAPinfo.com is now live and provides physicians with practical steps and training materials for use of BiPAP with intubated COVID-19 patients suffering respiratory failure.
Dr. Eddie Fatakhov, MD, a board-certified internist from Atlanta discusses the efficiency and effectiveness of Far-UV Light and how it is able to kill the COVID-19 Coronavirus in one-tenth of a second, while not harming human skin or eyesight, and eliminating inefficient and ineffective continual hand washing and hand sanitizing. It is a special lamp with a particular patented form of UV light known as “Excimer Wave Sterilray™” light, with a wavelength at 222 nm (nanometers), a form of Far-UV light that has a very short range in biological material but it can penetrate and kill viruses floating in the air, on surfaces, in liquids, etc., including COVID-19, disrupting its DNA structure and amino acids, killing it. He hopes for FDA approval and funding for mass production of these Far-UV lights that can save millions of lives and end the COVID-19 Coronavirus Pandemic, as well as annihilate future epidemics in their infancy.
Indy car driver, Charlie Kimball, talks about managing his type 1 diabetes with a continuous glucose monitor (CGM) that has made it possible for him to know his blood sugar numbers in nearly real-time and make small but meaningful adjustments to his insulin dosing throughout the day. He also discusses his 12th race season working with Novo Nordisk’s Race with Insulin® program.